Oil Spikes As Geopolitical Tensions Ignite Stagflation Fears

Asian Markets Slump As Middle East Conflict Drives Oil Spike

Escalating Middle East conflicts have driven oil prices near $119, triggering severe market sell-offs and forcing investors to rethink the Federal Reserve's rate-cut trajectory. Strong dollar flows are simultaneously crushing gold prices while markets brace for critical new economic data.

🛢️ Brent crude hits $119 on Middle East tensions.
🏦 Fed rate cuts unlikely amid high inflation fears.
🥇 Gold drops 11% due to a strengthening dollar.
🧬 Apogee Therapeutics reports critical Phase 2 trial data.

Asian Markets Slump as Iran Conflict Escalates

Asian equities faced a harsh sell-off on Monday, highlighted by a 3.3% drop in Japan's Nikkei 225, after hopes for a swift resolution to the Iran conflict faded. Brent crude surged to nearly $119 per barrel as the war entered its fourth week, intensifying global stagflation and recession fears. For more details, read the coverage from the Associated Press.

Key Assets to Watch: $BNO, $EWJ — The United States Brent Oil Fund ($BNO) will surge as supply shocks elevate crude prices, while the iShares MSCI Japan ETF ($EWJ) faces downside pressure from regional risk-off sentiment.

Fed Rate Cut Expectations Dwindle Amid "Oil Shock"

Investors are rapidly pricing in a "higher-for-longer" monetary environment after the Federal Reserve held rates at 3.5%–3.75%. Soaring energy costs threaten to push inflation up to 2.7% by year-end, leading analysts to project a maximum of one 0.25% rate cut in 2026. Read the full analysis by CBS News.

Key Assets to Watch: $TLT, $USO — The iShares 20+ Year Treasury Bond ETF ($TLT) will decline as bond yields rise on sustained higher interest rates, whereas the United States Oil Fund ($USO) stands to gain directly from the inflationary energy spike.

Gold Prices Plunge 11% as US Dollar Strengthens

In a surprising divergence from its safe-haven reputation, gold prices plummeted 11% over the past week to break below $4,500 per ounce. This steep decline is driven by a massive capital rotation into the US dollar, which has appreciated 2% since the geopolitical conflict began, making yield-bearing assets much more attractive. Additional insights are available via Trading Economics.

Key Assets to Watch: $GLD, $UUP — The SPDR Gold Shares ($GLD) will see continued heavy selling pressure as non-yielding bullion loses favor, while the Invesco DB US Dollar Index Bullish Fund ($UUP) will break out higher as currency flows flock to the greenback.

Corporate Spotlight: Apogee Therapeutics Trial Data

Outside of macroeconomics, biotech markets are highly focused on Apogee Therapeutics as they release 52-week data from their Phase 2 APEX trial for atopic dermatitis. This high-stakes conference call could trigger a massive valuation shift for the clinical-stage biologic developer depending on the efficacy and safety outcomes. Read more on Nasdaq.

Key Assets to Watch: $APGE, $XBI — Apogee Therapeutics ($APGE) will experience extreme price volatility based on its trial results, potentially injecting bullish or bearish momentum into the broader SPDR S&P Biotech ETF ($XBI).